Durham, North Carolina
United States
46
2026-05-14
The entities that hold a legal rights for patent applications filed by inventor Bartsevich Victor:
Victor Bartsevich from Durham, US has applied for patents for these inventions. The list has both pending applications and granted patents:
GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#2 | 2026-01-29ANTIBODIES AND FRAGMENTS SPECIFIC FOR B-CELL MATURATION ANTIGEN AND USES THEREOF
#3 | 2025-05-29OPTIMIZED ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME
#4 | 2025-05-15ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE
#5 | 2025-04-17TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES
#6 | 2025-03-13PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES
#7 | 2025-01-23ENGINEERED NUCLEASES THAT TARGET HUMAN AND CANINE FACTOR VIII GENES AS A TREATMENT FOR HEMOPHILIA A
#8 | 2024-11-21NUCLEIC ACIDS ENCODING ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#9 | 2024-07-18TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES
#10 | 2024-03-28ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE
#11 | 2024-03-28ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE
#12 | 2024-02-15ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE
#13 | 2024-02-01OPTIMIZED ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME
#14 | 2024-01-04GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#15 | 2023-06-29PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES
#16 | 2023-06-22TREATMENT OF RETINITIS PIGMENTOSA USING IMPROVED ENGINEERED MEGANUCLEASES
#17 | 2022-06-23ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A
#18 | 2022-05-19NUCLEIC ACIDS ENCODING ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#19 | 2022-05-12GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#20 | 2022-05-12TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES
#21 | 2022-05-05GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#22 | 2022-02-24Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
#23 | 2021-07-29PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES
#24 | 2021-07-08Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#25 | 2021-02-25Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
#26 | 2021-02-04ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE
#27 | 2021-01-07TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES
#28 | 2020-09-24ENGINEERED NUCLEASES THAT TARGET HUMAN AND CANINE FACTOR VIII GENES AS A TREATMENT FOR HEMOPHILIA A
#29 | 2020-06-11Treatment of retinitis pigmentosa using engineered meganucleases
#30 | 2020-04-30Engineered meganucleases specific for recognition sequences in the PCSK9 gene
#31 | 2019-11-07Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
#32 | 2019-06-27GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#33 | 2019-05-16Engineered nucleases useful for treatment of hemophilia A
#34 | 2019-01-17ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE
#35 | 2018-12-06PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES
#36 | 2018-10-11Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
#37 | 2018-09-20Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#38 | 2018-09-13Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#39 | 2018-09-06Treatment of retinitis pigmentosa using engineered meganucleases
#40 | 2018-05-24Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#41 | 2018-05-17Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#42 | 2018-05-15Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#43 | 2018-04-24Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#44 | 2018-04-24Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#45 | 2017-11-23Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#46 | 2017-11-23Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
2043026 ⎘